XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,420 $ 3,078
Accounts receivable, net of allowances of $65 in 2024 and $62 in 2023 1,729 1,719
Inventories 2,103 1,918
Prepaid expenses and other current assets 720 706
Current assets of discontinued operations 2,892 2,179
Total current assets 8,864 9,600
Property, plant and equipment, net 2,833 2,871
Goodwill 5,783 5,793
Other intangible assets, net 5,449 5,918
Operating lease right-of-use assets 327 336
Other non-current assets 886 809
Non-current assets of discontinued operations 2,534 2,949
Total assets 26,676 28,276
Current liabilities:    
Current maturities of long-term debt and finance lease obligations 2,498 2,667
Accounts payable 841 881
Accrued expenses and other current liabilities 1,772 1,915
Current liabilities of discontinued operations 1,089 1,040
Total current liabilities 6,200 6,503
Long-term debt and finance lease obligations, less current portion 10,437 11,089
Operating lease liabilities 259 265
Other non-current liabilities 1,263 1,400
Non-current liabilities of discontinued operations 575 551
Total liabilities 18,734 19,808
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2024 and 2023 683 683
Common stock in treasury, at cost, 173,032,822 shares in 2024 and 175,861,893 shares in 2023 (11,084) (11,230)
Additional contributed capital 6,391 6,389
Retained earnings 15,529 16,114
Accumulated other comprehensive loss (3,647) (3,554)
Total Baxter stockholders’ equity 7,872 8,402
Noncontrolling interests 70 66
Total equity 7,942 8,468
Total liabilities and equity $ 26,676 $ 28,276